Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_assertion type Assertion NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_head.
- NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_assertion wasGeneratedBy ECO_0000203 NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_provenance.
- NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_assertion wasDerivedFrom befree-20150227 NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_provenance.
- NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_assertion SIO_000772 23924660 NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_provenance.
- NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_assertion evidence source_evidence_literature NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_provenance.
- NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_assertion description "[Treatment of hepatitis C virus (HCV) infection with boceprevir, peginterferon, and ribavirin can lead to anemia, which has been managed by reducing ribavirin dose and/or erythropoietin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377856.RAD8KXNt04Ae7_tfXR5oIWLdJ3tc9xn5kuByWfqA6Wnv8130_provenance.